Answers are grounded in this paper and cite their sources.
This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: